Enhanced gap junction expression in myoblast-containing engineered tissue

Biochemical and Biophysical Research Communications

Volumn 422, Issue 3, 2012, Pages 462-468

  Perumal Srinivasan, Sureshkumar ^a   Neef, Klaus ^a   Treskes, Philipp ^a   Liakopoulos, Oliver J ^a   Stamm, Christof ^b,c   Cowan, Douglas B ^d   Madershahian, Navid ^a   Kuhn, Elmar ^a   Slottosch, Ingo ^a   Wittwer, Thorsten ^a   Wahlers, Thorsten ^a   Choi, Yeong Hoon ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

^b DEUTSCHES HERZZENTRUM BERLIN   (Germany)

^c Berlin Brandenburg Center for Regenerative Therapies   (Germany)

^d BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

Cardiac cell therapy; Connexin; Engineered tissue construct; Skeletal myoblast cell

Indexed keywords

DESMIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL ADHESION; CELL COMMUNICATION; CELL DIFFERENTIATION; CELL ISOLATION; CELL POPULATION; CELL STRUCTURE; CELL SURVIVAL; GAP JUNCTION; MOUSE; MUSCLE TISSUE; MYOBLAST; MYOTUBE; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TENSILE STRENGTH; TISSUE ENGINEERING;

ANIMALS; ANIMALS, NEWBORN; CELL SEPARATION; GAP JUNCTIONS; MICE; MICE, INBRED C57BL; MYOBLASTS, SKELETAL; TISSUE ENGINEERING; WEIGHT-BEARING;

MUS;

EID: 84861958479     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2012.05.016     Document Type: Article

References (39)

1. Bui A.L., Horwich T.B., Fonarow G.C. Epidemiology and risk profile of heart failure. Nat. Rev. Cardiol. 2010.
2. WHO, The global burden of disease: 2004 update, (2008).
3. Nicolini F., Gherli T. Alternatives to transplantation in the surgical therapy for heart failure. Eur. J. Cardiothorac. Surg. 2009, 35:214-228.
4. Dowell J.D., Rubart M., Pasumarthi K.B., Soonpaa M.H., Field L.J. Myocyte and myogenic stem cell transplantation in the heart. Cardiovasc. Res. 2003, 58:336-350.
5. Menasche P. Cardiac cell therapy: lessons from clinical trials. J. Mol. Cell. Cardiol. 2010.
6. Laflamme M.A., Murry C.E. Heart regeneration. Nature 2011, 473:326-335.
7. Murry C.E., Wiseman R.W., Schwartz S.M., Hauschka S.D. Skeletal myoblast transplantation for repair of myocardial necrosis. J. Clin. Invest. 1996, 98:2512-2523.
8. Menasche P. Skeletal myoblasts and cardiac repair. J. Mol. Cell. Cardiol. 2008, 45:545-553.
9. Menasche P., Hagege A.A., Scorsin M., Pouzet B., Desnos M., Duboc D., Schwartz K., Vilquin J.T., Marolleau J.P. Myoblast transplantation for heart failure. Lancet 2001, 357:279-280.
10. Menasche P., Alfieri O., Janssens S., McKenna W., Reichenspurner H., Trinquart L., Vilquin J.T., Marolleau J.P., Seymour B., Larghero J., Lake S., Chatellier G., Solomon S., Desnos M., Hagege A.A. The myoblast autologous grafting in ischemic cardiomyopathy (MAGIC) trial: first randomized placebo-controlled study of myoblast transplantation. Circulation 2008, 117:1189-1200.
11. Hagege A.A., Marolleau J.P., Vilquin J.T., Alheritiere A., Peyrard S., Duboc D., Abergel E., Messas E., Mousseaux E., Schwartz K., Desnos M., Menasche P. Skeletal myoblast transplantation in ischemic heart failure: long-term follow-up of the first phase I cohort of patients. Circulation 2006, 114:I108-I113.
12. Menasche P., Hagege A.A., Vilquin J.T., Desnos M., Abergel E., Pouzet B., Bel A., Sarateanu S., Scorsin M., Schwartz K., Bruneval P., Benbunan M., Marolleau J.P., Duboc D. Autologous skeletal myoblast transplantation for severe postinfarction left ventricular dysfunction. J. Am. Coll. Cardiol. 2003, 41:1078-1083.
13. Leobon B., Garcin I., Menasche P., Vilquin J.T., Audinat E., Charpak S. Myoblasts transplanted into rat infarcted myocardium are functionally isolated from their host. Proc. Natl. Acad. Sci. USA 2003, 100:7808-7811.
14. Hagege A.A., Carrion C., Menasche P., Vilquin J.T., Duboc D., Marolleau J.P., Desnos M., Bruneval P. Viability and differentiation of autologous skeletal myoblast grafts in ischaemic cardiomyopathy. Lancet 2003, 361:491-492.
15. Abraham M.R., Henrikson C.A., Tung L., Chang M.G., Aon M., Xue T., Li R.A., B O.R., Marban E. Antiarrhythmic engineering of skeletal myoblasts for cardiac transplantation. Circ. Res. 2005, 97:159-167.
16. Iijima Y., Nagai T., Mizukami M., Matsuura K., Ogura T., Wada H., Toko H., Akazawa H., Takano H., Nakaya H., Komuro I. Beating is necessary for transdifferentiation of skeletal muscle-derived cells into cardiomyocytes. FASEB J. 2003, 17:1361-1363.
17. Roell W., Lewalter T., Sasse P., Tallini Y.N., Choi B.R., Breitbach M., Doran R., Becher U.M., Hwang S.M., Bostani T., von Maltzahn J., Hofmann A., Reining S., Eiberger B., Gabris B., Pfeifer A., Welz A., Willecke K., Salama G., Schrickel J.W., Kotlikoff M.I., Fleischmann B.K. Engraftment of connexin 43-expressing cells prevents post-infarct arrhythmia. Nature 2007, 450:819-824.
18. Zhang M., Methot D., Poppa V., Fujio Y., Walsh K., Murry C.E. Cardiomyocyte grafting for cardiac repair:graft cell death and anti-death strategies. J. Mol. Cell. Cardiol. 2001, 907-921.
19. Choi Y.H., Stamm C., Hammer P.E., Kwaku K.F., Marler J.J., Friehs I., Jones M., Rader C.M., Roy N., Eddy M.T., Triedman J.K., Walsh E.P., McGowan F.X., Jr., del Nido P.J., Cowan D.B. Cardiac conduction through engineered tissue. Am. J. Pathol. 2006, 169:72-85.
20. Rando T.A., Blau H.M. Primary mouse myoblast purification characterization and transplantation for cell-mediated gene therapy. J. Cell Biol. 1994, 125(6):1275-1287.
21. Rando T.A., Blau H.M. Primary mouse myoblast purification, characterization, and transplantation for cell-mediated gene therapy. J. Cell Biol. 1994, 125:1275-1287.
22. Kaufman S.J., Foster R.F. Replicating myoblasts express a muscle-specific phenotype. Proc. Natl. Acad. Sci. USA 1988, 85:9606-9610.
23. Mege R.M., Goudou D., Diaz C., Nicolet M., Garcia L., Geraud G., Rieger F. N-cadherin and N-CAM in myoblast fusion: compared localisation and effect of blockade by peptides and antibodies. J. Cell Sci. 1992, 103(Pt 4):897-906.
24. Blocklet D., Toungouz M., Berkenboom G., Lambermont M., Unger P., Preumont N., Stoupel E., Egrise D., Degaute J.P., Goldman M., Goldman S. Myocardial homing of nonmobilized peripheral-blood CD34+ cells after intracoronary injection. Stem Cells 2006, 24:333-336.
25. Hofmann M., Wollert K.C., Meyer G.P., Menke A., Arseniev L., Hertenstein B., Ganser A., Knapp W.H., Drexler H. Monitoring of bone marrow cell homing into the infarcted human myocardium. Circulation 2005, 111:2198-2202.
26. Pagani F.D., DerSimonian H., Zawadzka A., Wetzel K., Edge A.S., Jacoby D.B., Dinsmore J.H., Wright S., Aretz T.H., Eisen H.J., Aaronson K.D. Autologous skeletal myoblasts transplanted to ischemia-damaged myocardium in humans. Histological analysis of cell survival and differentiation. J. Am. Coll. Cardiol. 2003, 41:879-888.
27. Eschenhagen T., Zimmermann W.H. Engineering myocardial tissue. Circ. Res. 2005, 97:1220-1231.
28. Buckberg G.D., Coghlan H.C., Torrent-Guasp F. The structure and function of the helical heart and its buttress wrapping. VI. Geometric concepts of heart failure and use for structural correction. Semin. Thorac. Cardiovasc. Surg. 2001, 13:386-401.
29. Makkar R.R., Lill M., Chen P.S. Stem cell therapy for myocardial repair: is it arrhythmogenic?. J. Am. Coll. Cardiol. 2003, 42:2070-2072.
30. Fernandes S., van Rijen H.V., Forest V., Evain S., Leblond A.L., Merot J., Charpentier F., de Bakker J.M., Lemarchand P. Cardiac cell therapy: overexpression of connexin43 in skeletal myoblasts and prevention of ventricular arrhythmias. J. Cell. Mol. Med. 2009, 13:3703-3712.
31. Li Y.G., Zhang P.P., Jiao K.L., Zou Y.Z. Knockdown of microRNA-181 by lentivirus mediated siRNA expression vector decreases the arrhythmogenic effect of skeletal myoblast transplantation in rat with myocardial infarction. Microvasc. Res. 2009, 78:393-404.
32. Du W.J., Li J.K., Wang Q.Y., Hou J.B., Yu B. Lithium chloride preconditioning optimizes skeletal myoblast functions for cellular cardiomyoplasty in vitro via glycogen synthase kinase-3beta/beta-catenin signaling. Cells Tissues Organs 2009, 190:11-19.
33. Shafy A., Lavergne T., Latremouille C., Cortes-Morichetti M., Carpentier A., Chachques J.C. Association of electrostimulation with cell transplantation in ischemic heart disease. J. Thorac. Cardiovasc. Surg. 2009, 138:994-991001.
34. Lee S.W., Kang H.J., Lee J.Y., Youn S.W., Won J.Y., Kim J.H., Lee H.C., Lee E.J., Oh S.I., Oh B.H., Park Y.B., Kim H.S. Oscillating pressure treatment upregulates connexin43 expression in skeletal myoblasts and enhances therapeutic efficacy for myocardial infarction. Cell Transplant. 2009, 18:1123-1135.
35. Gomez G.A., McLachlan R.W., Yap A.S. Productive tension: force-sensing and homeostasis of cell-cell junctions. Trends Cell Biol. 2011, 21:499-505.
36. Wang N., Tytell J.D., Ingber D.E. Mechanotransduction at a distance: mechanically coupling the extracellular matrix with the nucleus. Nat. Rev. Mol. Cell Biol. 2009, 10:75-82.
37. Leckband D.E., le Duc Q., Wang N., de Rooij J. Mechanotransduction at cadherin-mediated adhesions. Curr. Opin. Cell Biol. 2011, 23:523-530.
38. Zhang H., Landmann F., Zahreddine H., Rodriguez D., Koch M., Labouesse M. A tension-induced mechanotransduction pathway promotes epithelial morphogenesis. Nature 2011, 471:99-103.
39. Bian W., Bursac N. Tissue engineering of functional skeletal muscle: challenges and recent advances. IEEE Eng. Med. Biol. Mag. 2008, 27:109-113.